RecruitingNot ApplicableNCT06993454

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis


Sponsor

AdventHealth Translational Research Institute

Enrollment

12 participants

Start Date

Apr 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).


Eligibility

Min Age: 25 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how a single bout of exercise affects blood sugar production from the liver in people with type 2 diabetes — and whether this response differs from healthy, lean individuals — to better understand how exercise works as a diabetes treatment. **You may be eligible if (type 2 diabetes group)...** - You are male or pre-menopausal female, aged 25–55 - You have type 2 diabetes with HbA1c of 7.5% or higher - You have excess liver fat (5.6% or above on MRI) - You are largely inactive (exercising 1 day or less per week) - Your weight has been stable for the past 3 months **You may NOT be eligible if...** - You are currently taking insulin, GLP-1 medications, or thiazolidinediones - You have serious heart, kidney, liver, or lung disease - You have resting blood pressure of 160/100 or higher - You have active cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMagnetic Resonance Liver Assessment

Liver fat will be measured by MR imaging to assess level of hepatic steatosis.

OTHERBike Exercise VO2max

Maximal fitness measured by cycle ergometer.

OTHERDEXA

Measure body composition (fat and lean body mass).


Locations(1)

AdventHealth Translational Research Institute

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06993454


Related Trials